Clinical Trial Update: Japanese Phase 1 Study of Mepolizumab [Phase 1]

View source ↗

Summary

This document reports the completion of a Japanese Phase 1 clinical trial evaluating mepolizumab for asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED